| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | $18.1B | $19.8B | $24.7B | $23.6B |
| Cost of Revenue | $12.4B | $13.3B | $16.8B | $16.8B |
| Gross Profit | — | — | — | — |
| R&D Expense | $1.0B | $0.9B | $1.0B | $0.9B |
| SG&A Expense | $1.9B | $1.7B | $1.9B | $1.8B |
| Operating Income | — | — | — | — |
| Net Income | $0.5B | $1.2B | $2.4B | $2.0B |
| EPS (Basic) | $0.41 | $0.99 | $1.78 | $1.50 |
| EPS (Diluted) | $0.41 | $0.99 | $1.76 | $1.49 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $42.7B | $42.9B | $46.4B | $39.4B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | $2.6B | $3.2B | $4.3B | $4.4B |
| Total Liabilities | $34.9B | $35.2B | $38.1B | $32.4B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $2.0B | $0.9B | $0.6B |
| Investing Cash Flow | $-1.4B | $-2.8B | $-3.7B | $-3.0B |
| Capital Expenditures | — | — | — | — |
| Financing Cash Flow | $-2.0B | $-0.1B | $2.6B | $2.0B |